KuDOS Pharmaceuticals' Acquisition

KuDOS Pharmaceuticals was acquired by AstraZeneca on December 23, 2005.

KuDOS is involved in the discovery and development of small molecule drugs based upon the science of DNA damage sensing, signalling and repair to address unmet medical needs in cancer treatment.…

Articles about KuDOS Pharmaceuticals' Acquisition: